ERK5 signalling in prostate cancer promotes an invasive phenotype.
about
ERK5 and Cell Proliferation: Nuclear Localization Is What MattersCanonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complexSrc-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cellsExpression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer.A novel high throughput invasion screen identifies host actin regulators required for efficient cell entry by Toxoplasma gondii.MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin.MEK5 overexpression is associated with the occurrence and development of colorectal cancerIdentifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.ERK5 negatively regulates tobacco smoke-induced pulmonary epithelial-mesenchymal transition.Role of MAPK7 in cell proliferation and metastasis in ovarian cancerAberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancerA comparison of epithelial-to-mesenchymal transition and re-epithelializationDownregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production.miR-139-5p is a regulator of metastatic pathways in breast cancer.Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.ERK5 and its role in tumour development.MiR-139-5p: promising biomarker for cancer.Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approachOncogenic signaling of MEK5-ERK5.Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation.Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity.WNK lysine deficient protein kinase 1 regulates human endometrial stromal cell decidualization, proliferation, and migration in part through mitogen-activated protein kinase 7.Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway.TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.Curcumin Suppresses MAPK Pathways to Reverse Tobacco Smoke-induced Gastric Epithelial-Mesenchymal Transition in Mice.
P2860
Q28078572-5B981684-C550-4B11-8006-BD8DF19502BFQ28854310-238C07B9-3D7B-4EA9-B0BA-5E7B64032478Q33851800-49398B3E-8E4B-46B2-87A3-01642994CE92Q34212935-E23A406F-0E22-4C59-AF8C-9ACA34644F89Q34760706-6B3C68B4-B15C-483F-8F48-E1A26DB91703Q35560430-98823C09-E7AC-4E2C-85AD-15F56D654FFDQ35853880-4A1C1910-98A0-471F-A98E-F36343B5BACAQ36012573-10DC3170-E45E-41B1-AB6A-ED48692FD3B4Q36173081-2FBAA89F-A83E-41B0-8626-E885AE0AC8DEQ36260600-53B6A2F0-3B3A-47D2-AD56-7B2D2BBA77DBQ36261403-70AAEAFD-A84D-4FCC-B4CF-29BBC6A1BE98Q36293295-F6A9095D-6E65-4457-B9AC-17374DC49F14Q36557814-B5084E82-F53D-40ED-9F9A-5308DAD47D82Q36678367-D52E11B4-C2BB-406F-8164-25C1A5F37EE1Q37388754-CD14E332-4C0B-400A-8EB8-7ED7C17376FEQ37448717-2ECA2C27-FA16-4C10-950C-DB4D77812F4EQ37556126-2A9FC03A-CE0D-45CE-AA0F-ED8E0FBC6E28Q37977186-C73C2125-C6CD-413F-B090-06049E8D3723Q38359431-DE2D853C-6EF6-4077-AE8D-E11D0AC73AB3Q38767469-7BEBEB4B-3E18-4837-B544-311CF7B15B5DQ38828361-7704F891-76D2-4544-BC22-5B1AE3400D73Q38849399-27407EEE-5F9B-4A0B-AB9D-9DBE08CAFF1EQ39116456-3A04BC0E-A4C6-4B52-B2AF-F1812F308202Q39450541-79C67C46-2448-408B-9506-F23948C0F8C9Q41033728-BBDE6D4D-043E-4DBE-A438-86878703578BQ41643520-E82A7237-E528-49C5-A9D5-AE4F3F816899Q42051316-6FA2861F-B699-4308-928A-F541653015B3Q42378808-0EDFAA89-A42D-4EF5-9126-28E6C04F8F34Q42778113-CDA3D338-EB8F-4497-BC10-657C42153BCAQ49798105-E21996BA-3C06-4B6A-AB52-509956D5A43CQ51164416-EF0831A4-8E98-47E1-B84C-3EFDE36CCFD7Q51337382-45228F30-AA05-4C0F-BA58-98E74FD6813DQ54265781-9D6348AC-8650-484E-8386-F9A8E0FD4DDA
P2860
ERK5 signalling in prostate cancer promotes an invasive phenotype.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@ast
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@en
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@nl
type
label
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@ast
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@en
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@nl
prefLabel
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@ast
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@en
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@nl
P2093
P2860
P356
P1476
ERK5 signalling in prostate cancer promotes an invasive phenotype.
@en
P2093
A K Ramsay
D R Edwards
L Machesky
M Seywright
P2860
P2888
P304
P356
10.1038/SJ.BJC.6606062
P407
P577
2011-01-25T00:00:00Z
P5875
P6179
1026744928